Marc Steven Abel, PhD
In this section
Dean, College of Pharmacy
Professor, Pharmaceutical Sciences, College of Pharmacy
Marc S. Abel, BS, BA, MS, PhD was appointed Dean and Chief Academic Officer of the College of Pharmacy on July 1, 2015. He received his BA and BS degrees in Psychology and Biology, respectively, from Oakland University in Rochester, Michigan. After earning his MS in Physiology from Wayne State University in Detroit, Michigan, he received his PhD in Biomedical Sciences (concentration: neuroscience) from the Department of Neurobiology and Anatomy at the University of Texas Medical Center in Houston, Texas. In 1981 Dr. Abel joined the pharmaceutical industry in the Department of CNS Biology and the Molecular Biology Group at Lederle Laboratories (American Cyanamid Company) in Pearl River, NY. His work focused on separating anxiolytic, muscle relaxant, amnestic, and anti-seizure effects of benzodiazepines, as well as identifying neuropharmacological bases for antidepressant therapies. He was also an adjunct assistant professor in the Department of Psychology at City College (City University of New York). In 1990 Dr. Abel joined the Chicago Medical School in the Department of Cell Biology and Anatomy. He was instrumental in the design of the Dr. John J. Sheinin Gross Anatomy Lab, led the Educational Affairs (curriculum) Committee at CMS for 9 years, was the first Director of the Office of Educational Technology at RFUMS, and was selected to serve as a Faculty Representative on the RFUMS Board of Trustees.
A founding member of the College of Pharmacy, Dr. Abel served as Associate Dean for Academic and Student Affairs, and subsequently as Vice Dean and Acting Dean, prior to being named Dean. Helping to establish all aspects of the new college, he was instrumental in developing the College curriculum, and led the effort to achieve full accreditation.
Dr. Abel conducted NIH-funded research on molecular alterations of the CNS GABA receptor induced by seizures. He has given many invited talks and presentations and is published in top journals, on topics ranging from his laboratory research to interprofessionalism. Dr. Abel was an editorial board member for Metabolic Brain Disease, has served as a reviewer for several other journals, and was a member of a neuroscience/pharmacology review panel at the NIH for many years.
Dr. Abel has extensive experience as an educator, including curriculum and course design, as well as undergraduate and graduate course direction and classroom teaching. He helped develop the interprofessional curriculum at RFUMS, and implemented new teaching methodologies in his courses. He has won several teaching awards, was inducted into the Master Teacher Guild and was selected to join the CMS chapter of the Alpha Omega Alpha Honor Medical Society.